Florida

Florida's life sciences ecosystem has evolved into a premier global destination for high-growth sectors, consistently ranking as a top-tier powerhouse for biotechnology R&D and pharmaceutical manufacturing.

The state is home to a thriving cluster of over 46,000 healthcare and life science establishments, anchored by the Miami Health District and Lake Nona Medical City, which serve as epicenters for healthcare innovation and clinical trial excellence.

Florida's world-class academic research institutions, including the University of Florida and USF, drive the commercialization of breakthroughs in precision medicine, cell and gene therapy and neuroscience.

As the nation's second-largest hub for medical device manufacturing, the state excels in producing cutting-edge diagnostic equipment, surgical robotics and patient-specific orthotics.

This robust bioscience ecosystem is supported by a massive healthcare workforce and a collaborative network of clinical-stage biotech companies and specialized hospitals like the Mayo Clinic.

Strategic investments in digital health, AI-enabled drug discovery and interoperability have positioned Florida at the forefront of the next generation of medical technology.

Furthermore, Florida facilitates international strategic partnerships and global market access for life science ventures.

Leveraging a pro-business environment and significant R&D expenditures, Florida continues to attract substantial venture capital and institutional funding.

From biologics development to advanced manufacturing, the Sunshine State offers a complete, integrated value chain for global life science organizations.